Camellia oil Enhances Plasma Antioxidant Metabolism and Improves Plasma Lipid Metabolism in High-fat Diet-fed Rats
Open Access
- 7 March 2022
- journal article
- research article
- Published by SAGE Publications in Natural Product Communications
- Vol. 17 (3)
Abstract
Living on a high-fat, high-calorie, and high-protein diet for a long period may compromise human immunity due to the long-term accumulation of free radicals and plasma lipids. The antioxidant and lipid-lowering compounds (ie polyphenols and vitamin E) in Camellia oil help to decrease the risk of numerous ailments, including cardiovascular disease (CVD), and obesity. The aims of this study were to study the hypolipidemic and antioxidant effects of Camellia oil in high-fat-fed rats and to promote the high-value use of camellia resources. The high-fat-fed rats were administrated with 2.5, 7.5, and 15 mL/kg BW Camellia oil (Camellia oil group), and 10 mg/kg BW atorvastatin (atorvastatin group), respectively, and compared with a model group (only fed with high fat) and a control group (fed with basal diet). Several parameters were measured, including (1) body weight (BW), liver-to-BW ratio; (2) plasma total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C); and (3) alanine aminotransferase (ALT), alanine aminotransferase (AST), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) activity, model driven architecture (MDA) content, lipid metabolism-related genes, and antioxidant-related genes in liver tissue. Compared with the model group, the high-fat-fed rats in the Camellia oil and atorvastatin group had significantly lower BW and liver-to-BW ratio ( P < .01), plasma TC, TG, and LDL-C levels and ALT and AST activities, but higher HDL-C levels. The relative expressions of ACAT1, DGAT2, FAS, and SREBP genes were significantly reduced in the Camellia oil and atorvastatin groups, while the relative expressions of LCAT, UCP2, MCD, and CPT-1 genes were significantly increased. The rats in the Camellia oil group showed significantly higher SOD and GSH-Px activities, significantly lower MDA content, and significantly higher relative expression of antioxidant genes (eg SOD1, GPx1, CAT, and Gclm). Thus, atorvastatin and Camellia oil exhibited significant hypolipidemic and antioxidant effects, which were better at a dose of 7.5 mL/kg (BW) of Camellia oil. Therefore, Camellia oil becomes a potential new natural resource for future research and development of antioxidant and hypolipidemic drugs, nutraceuticals, and additives.Keywords
Funding Information
- Ph.D. introduction of scientific research projects (2021HYBS03)
- Hunan Province Key R&D Program of China (2017NK2071, 2018NK2013)
This publication has 32 references indexed in Scilit:
- A New Saponin from Tea Seed Pomace (Camellia oleifera Abel) and Its Protective Effect on PC12 CellsMolecules, 2012
- Bioactivities of water-soluble polysaccharides from fruit shell of Camellia oleifera Abel: Antitumor and antioxidant activitiesCarbohydrate Polymers, 2012
- MicroRNA-370 controls the expression of MicroRNA-122 and Cpt1α and affects lipid metabolismJournal of Lipid Research, 2010
- The effect of aging on the response of isolated hepatocytes to hydrogen peroxide and tert-butyl hydroperoxideToxicology in Vitro, 2010
- n-3 Fatty Acids Reduce Arterial LDL-Cholesterol Delivery and Arterial Lipoprotein Lipase Levels and Lipase DistributionArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Omega-3 fatty acid containing diets decrease plasma triglyceride concentrations in mice by reducing endogenous triglyceride synthesis and enhancing the blood clearance of triglyceride-rich particlesClinical Nutrition, 2008
- Mechanisms of γ-glutamylcysteine ligase regulationBiochimica et Biophysica Acta (BBA) - General Subjects, 2006
- Biomarkers and potential mechanisms of obesity-induced oxidant stress in humansInternational Journal of Obesity, 2005
- Dietary Conjugated Linoleic Acid Reduces Lipid Peroxidation by Increasing Oxidative Stability in RatsJournal of Nutritional Science and Vitaminology, 2005
- Optimal management of hyperlipidemia in primary prevention of cardiovascular diseaseInternational Journal of Cardiology, 2004